TOP 2301: Neoadjuvant Chemo for NSCLC
Conditions: Non Small Cell Lung Cancer Interventions: Drug: Alirocumab; Drug: Cemiplimab; Drug: Chemotherapy Sponsors: Duke University; Regeneron Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials